HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Energostim in therapy of chronic ischemia of the lower limbs.

Abstract
Positive changes were more pronounced in patients with chronic ischemia of the lower limbs treated with energostim alone and in combination with trental in comparison with patients receiving trental monotherapy. The best effect was attained in patients treated with energostim in combination with trental.
AuthorsP A Galenko-Yaroshevskii, O A Alukhanyan, O V Kurganskii, Yu Yu Fedchenko
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 138 Issue 2 Pg. 144-7 (Aug 2004) ISSN: 0007-4888 [Print] United States
PMID15662456 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Drug Combinations
  • energostim
  • NAD
  • Inosine
  • Cytochromes c
  • Pentoxifylline
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Arteriosclerosis (drug therapy)
  • Coronary Disease (complications)
  • Cytochromes c (therapeutic use)
  • Drug Combinations
  • Echocardiography
  • Female
  • Humans
  • Inosine (therapeutic use)
  • Ischemia (diagnosis, drug therapy, etiology)
  • Laser-Doppler Flowmetry
  • Leg (blood supply)
  • Male
  • Microcirculation
  • Middle Aged
  • NAD (therapeutic use)
  • Pentoxifylline (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: